Antidepressants in clinical practice: Limitations of assessment methods and drug response

被引:35
|
作者
Kennedy, SH [1 ]
Eisfeld, BS [1 ]
Meyer, JH [1 ]
Bagby, RM [1 ]
机构
[1] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5T 1RB, Canada
关键词
antidepressants; efficacy; diagnostic heterogeneity functional brain imaging; Major Depressive Disorder;
D O I
10.1002/hup.189
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is a recognized gap between knowledge derived from 'efficacy' data - based on usually brief randomized controlled trials and findings in natural practice 'effectiveness' studies. In considering the limitations of current antidepressants in clinical practice, we have selected three clinically important issues to examine in a natural practice data base that has been in existence for several years. These relate to: (I) Diagnostic heterogeneity and potential advances using functional brain imaging; (2) Variability of outcome measures during treatment and (3) Time to response and prediction of outcome. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:105 / 114
页数:10
相关论文
共 50 条
  • [41] Reliability of the assessment of preventable adverse drug events in daily clinical practice
    van Doormaal, Jasperien E.
    Mol, Peter G. M.
    van den Bemt, Patricia M. L. A.
    Zaal, Rianne J.
    Egberts, Antoine C. G.
    Kosterink, Jos G. W.
    Haaijer-Ruskamp, Flora M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (07) : 645 - 654
  • [42] Assessment of drug-induced hepatotoxicity in clinical practice:: A challenge for gastroenterologists
    Andrade, Raul J.
    Robles, Mercedes
    Fernandez-Castaner, Alejandra
    Lopez-Ortega, Susana
    Lopez-Vega, M. Carmen
    Lucena, M. Isabel
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (03) : 329 - 340
  • [43] On the limitations of health impact assessment Response
    Metcalfe, O.
    PUBLIC HEALTH, 2009, 123 (12) : 820 - 821
  • [44] Assessment methods in the chronobiology of bipolar disorder: From research to clinical practice?
    Murray, G.
    BIPOLAR DISORDERS, 2019, 21 : 24 - 24
  • [45] Assessment of Potential Drug-Drug Interactions of Psycholeptics and Antidepressants in Outpatient Settings
    Marovic, Iva
    Marinovic, Ivana
    Vrca, Vesna Bacic
    Samardzic, Ivana
    PHARMACY, 2024, 12 (06)
  • [46] Clinical limitations of risk assessment models
    Lassen, MR
    Borris, LC
    Backs, S
    Kaltoft-Sorensen, M
    Coff-Ganes, H
    Jeppesen, E
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 : S45 - S51
  • [47] Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice
    Lozano-Blazquez, Ana
    Calvo-Pita, Cecilia
    Carbajales-Alvarez, Monica
    Suarez-Gil, Patricio
    Martinez-Martinez, Fernando
    Angel Calleja-Hernandez, Miguel
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 527 - 535
  • [48] Adverse Drug Reactions in Clinical Practice: a Causality Assessment of a Case of Drug-Induced Pancreatitis
    Farcas, Andreea
    Bojita, Marius
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2009, 18 (03) : 353 - 358
  • [49] Clinical practice guidelines: Concepts, limitations and challenges
    Ariel Franco, Juan Victor
    Arancibia, Marcelo
    Meza, Nicolas
    Madrid, Eva
    Kopitowski, Karin
    MEDWAVE, 2020, 20 (03):
  • [50] Applications and limitations in translating genomics to clinical practice
    Van Ness, Brian
    TRANSLATIONAL RESEARCH, 2016, 168 : 1 - 5